PHOENIX-GC Trial: Underpowered for Significant Results?

Affiliations

Comment

Ziyu Li et al. J Clin Oncol. 2019.

. 2019 Jan 10;37(2):167.

doi: 10.1200/JCO.18.00364. Epub 2018 Nov 26.

¹ Ziyu Li, MD; Kan Xue, MD; Xiangji Ying, MPH; and Jiafu Ji, PhD, MD, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.

No abstract available

Comment in

Reply to Z. Li et al.
Ishigami H. Ishigami H. J Clin Oncol. 2019 Jan 10;37(2):167-168. doi: 10.1200/JCO.18.01003. Epub 2018 Nov 26. J Clin Oncol. 2019. PMID: 30475667 No abstract available.

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, Imamoto H, Kodera Y, Uenosono Y, Amagai K, Kadowaki S, Miwa H, Yamaguchi H, Yamaguchi T, Miyaji T, Kitayama J. Ishigami H, et al. J Clin Oncol. 2018 Jul 1;36(19):1922-1929. doi: 10.1200/JCO.2018.77.8613. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746229 Clinical Trial.